Paper30107136
A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018).
Shaabani S and 7 others. Expert Opin Ther Pat, 2018. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018). Papers, record 30107136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30107136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018).
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B7-H1 Antigen | Major topic |
| Drug Design | Major topic |
| Programmed Cell Death 1 Receptor | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Antineoplastic Agents | |
| Humans | |
| Macrocyclic Compounds | |
| Neoplasms | |
| Patents as Topic | |
| Peptides |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM097082 | NIGMS NIH HHS | United States | R01GM097082 | PubMed and NIH |
Source NIH RePORTER
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27367741 | Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015). | Expert Opin Ther Pat | 2016 | https://conductscience.org/library/papers/27367741 | PubMed |
| 2 | 28881104 | Bioactive Macrocyclic Inhibitors of the PD-1/PD-L1 Immune Checkpoint. | Angew Chem Int Ed Engl | 2017 | https://conductscience.org/library/papers/28881104 | PubMed |
| 3 | 27083005 | Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1). | Oncotarget | 2016 | https://conductscience.org/library/papers/27083005 | PubMed |
| 4 | 29069777 | Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/29069777 | PubMed |
| 5 | 28613862 | Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1. | J Med Chem | 2017 | https://conductscience.org/library/papers/28613862 | PubMed |
| 6 | 29178534 | Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies? | Angew Chem Int Ed Engl | 2018 | https://conductscience.org/library/papers/29178534 | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42185552 | In silico discovery of novel small-molecule PD-L1 inhibitors through a multi-stage computational workflow integrating machine learning and molecular dynamics. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42185552 | PubMed |
| 41783574 | Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41783574 | PubMed |
| 41670748 | Exploring FDA-approved small molecules for their potential as PD-1/PD-L1 inhibitors: integrating computational screening with experimental testing. | J Mol Model | 2026 | https://conductscience.org/library/papers/41670748 | PubMed |
| 41502772 | Study on the Molecular Dynamics of 2‑(4-Fluorophenyl)-6-methyl-4-(3- (trifluoromethyl)phenyl)-1,2-dihydrodipyrazolo[3,4-b:3',4'‑d]pyridin-3(6H)‑one for Cancer Immunotherapy Using a DFT Model. | ACS Omega | 2025 | https://conductscience.org/library/papers/41502772 | PubMed |
| 40948850 | A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategies. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/40948850 | PubMed |
| 40872601 | Discovery of Small-Molecule PD-L1 Inhibitors via Virtual Screening and Their Immune-Mediated Anti-Tumor Effects. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872601 | PubMed |
| 39494025 | A PD-L1-Targeted Probe Cy5.5-A11 for In Vivo Imaging of Multiple Tumors. | ACS Omega | 2024 | https://conductscience.org/library/papers/39494025 | PubMed |
| 39411933 | In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers. | Anticancer Agents Med Chem | 2025 | https://conductscience.org/library/papers/39411933 | PubMed |
| 39324857 | Esterase responsive release of anti-cancer agents from conjugated lipid nanocarrier and the regulatory considerations. | Pharm Pat Anal | 2024 | https://conductscience.org/library/papers/39324857 | PubMed |
| 39121024 | In silico exploration of PD-L1 binding compounds: Structure-based virtual screening, molecular docking, and MD simulation. | PLoS One | 2024 | https://conductscience.org/library/papers/39121024 | PubMed |
| 38734315 | Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics. | J Control Release | 2024 | https://conductscience.org/library/papers/38734315 | PubMed |
| 38731999 | The Role of TRP Channels in Sepsis and Colitis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731999 | PubMed |
| 38706351 | Structural Insights of PD-1/PD-L1 Axis: An In silico Approach. | Curr Protein Pept Sci | 2024 | https://conductscience.org/library/papers/38706351 | PubMed |
| 38701786 | Molecular glues for protein-protein interactions: Progressing toward a new dream. | Cell Chem Biol | 2024 | https://conductscience.org/library/papers/38701786 | PubMed |
| 38665838 | Progress in small-molecule inhibitors targeting PD-L1. | RSC Med Chem | 2024 | https://conductscience.org/library/papers/38665838 | PubMed |
| 38665826 | 1,5-Disubstituted tetrazoles as PD-1/PD-L1 antagonists. | RSC Med Chem | 2024 | https://conductscience.org/library/papers/38665826 | PubMed |
| 38442487 | Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1. | J Med Chem | 2024 | https://conductscience.org/library/papers/38442487 | PubMed |
| 38426097 | From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/38426097 | PubMed |
| 38312352 | Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancer. | BJC Rep | 2024 | https://conductscience.org/library/papers/38312352 | PubMed |
| 38229762 | Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m-Terphenyl Derivatives. | ACS Med Chem Lett | 2024 | https://conductscience.org/library/papers/38229762 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| HAVCR2 | 84868 | PubTator's text mining | https://conductscience.org/library/genes/84868 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| LAG3 | 3902 | PubTator's text mining | https://conductscience.org/library/genes/3902 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| PDCD1LG2 | 80380 | PubTator's text mining | https://conductscience.org/library/genes/80380 | NCBI Gene |
| VSIR | 64115 | PubTator's text mining | https://conductscience.org/library/genes/64115 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30107136
GET https://conductscience.org/api/papers/v1/30107136/cited_by?page=2